Investigate how vestibulospinal pathways contribute to spasticity and abnormal muscle co-activation after stroke, and advance our understanding of brainstem circuit mechanisms underlying motor ...

The FDA has approved the expanded use of Botox® (onabotulinumtoxinA; Allergan) for the treatment of spasticity in pediatric patients aged ≥2 years, including those with lower limb spasticity caused by ...

Researchers have made a significant advancement in the field of spinal cord injury research, developing a novel optogenetic mouse model that could lead to improved treatments for limb spasticity.

Cerebral Palsy has been linked to a condition called cryptorchidism in males - when one or both of the testicles are not present in the scrotum. A new study in Developmental Medicine & Child Neurology ...

PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced topline results for two double-blind phase III studies of Dysport® (abobotulinumtoxinA) in Pediatric Lower ...

The Department of Health has asked us to carry out a Multiple Technology Appraisal of botulinum toxin type A preparations (Botox, Dysport, and Xeomin) within their marketing authorisations for ...

The finding is the first to validate the test as a tool to measure performance for lower-limb amputees using bone-anchored prostheses. The study was published recently in the Journal of Bone & Joint ...